| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 9869 | 2021 |
| Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells M Ghaffari, G Dehghan, B Baradaran, A Zarebkohan, B Mansoori, ... Colloids and Surfaces B: Biointerfaces 188, 110762, 2020 | 140 | 2020 |
| Exosomal delivery of therapeutic modulators through the blood–brain barrier; promise and pitfalls M Heidarzadeh, Y Gürsoy-Özdemir, M Kaya, A Eslami Abriz, ... Cell & Bioscience 11, 1-28, 2021 | 122 | 2021 |
| Significant role of cationic polymers in drug delivery systems M Farshbaf, S Davaran, A Zarebkohan, N Annabi, A Akbarzadeh, ... Artificial cells, nanomedicine, and biotechnology 46 (8), 1872-1891, 2018 | 108 | 2018 |
| Targeted drug delivery based on gold nanoparticle derivatives M Gholipourmalekabadi, M Mobaraki, M Ghaffari, A Zarebkohan, ... Current pharmaceutical design 23 (20), 2918-2929, 2017 | 100 | 2017 |
| Smart and biomimetic 3D and 4D printed composite hydrogels: opportunities for different biomedical applications S Malekmohammadi, N Sedghi Aminabad, A Sabzi, A Zarebkohan, ... Biomedicines 9 (11), 1537, 2021 | 85 | 2021 |
| Cell surface GRP78: An emerging imaging marker and therapeutic target for cancer M Farshbaf, AY Khosroushahi, S Mojarad-Jabali, A Zarebkohan, ... Journal of Controlled Release 328, 932-941, 2020 | 85 | 2020 |
| Synthesis and characterization of a PAMAM dendrimer nanocarrier functionalized by SRL peptide for targeted gene delivery to the brain A Zarebkohan, F Najafi, HR Moghimi, M Hemmati, MR Deevband, ... European Journal of Pharmaceutical Sciences 78, 19-30, 2015 | 85 | 2015 |
| The impact of protein corona on the biological behavior of targeting nanomedicines M Farshbaf, H Valizadeh, Y Panahi, Y Fatahi, M Chen, A Zarebkohan, ... International Journal of Pharmaceutics 614, 121458, 2022 | 72 | 2022 |
| Crosstalk between chitosan and cell signaling pathways B Farhadihosseinabadi, A Zarebkohan, M Eftekhary, M Heiat, ... Cellular and Molecular Life Sciences 76, 2697-2718, 2019 | 65 | 2019 |
| Protein corona and exosomes: new challenges and prospects M Heidarzadeh, A Zarebkohan, R Rahbarghazi, E Sokullu Cell Communication and Signaling 21 (1), 64, 2023 | 61 | 2023 |
| Advanced bioresponsive multitasking hydrogels in the new era of biomedicine M Niazi, E Alizadeh, A Zarebkohan, K Seidi, MH Ayoubi‐Joshaghani, ... Advanced Functional Materials 31 (41), 2104123, 2021 | 61 | 2021 |
| AS1411 aptamer-functionalized chitosan-silica nanoparticles for targeted delivery of epigallocatechin gallate to the SKOV-3 ovarian cancer cell lines L Alizadeh, E Alizadeh, A Zarebkohan, E Ahmadi, M Rahmati-Yamchi, ... Journal of Nanoparticle Research 22, 1-14, 2020 | 58 | 2020 |
| Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers M Farshbaf, S Mojarad-Jabali, S Hemmati, AY Khosroushahi, ... Journal of Controlled Release 345, 371-384, 2022 | 45 | 2022 |
| Cytotoxicity characteristics of green assisted-synthesized superparamagnetic maghemite (γ-Fe2O3) nanoparticles A Bali Ogholbeyg, A Kianvash, A Hajalilou, E Abouzari-Lotf, ... Journal of Materials Science: Materials in Electronics 29, 12135-12143, 2018 | 40 | 2018 |
| Chitosan-based nanotherapeutics for ovarian cancer treatment L Alizadeh, A Zarebkohan, R Salehi, A Ajjoolabady, M Rahmati-Yamchi Journal of drug targeting 27 (8), 839-852, 2019 | 38 | 2019 |
| Targeted co-delivery of curcumin and doxorubicin by citric acid functionalized Poly (ε-caprolactone) based micelle in MDA-MB-231 cell A Sabzi, A Rahmani, M Edalati, H Kahroba, MR Dadpour, R Salehi, ... Colloids and Surfaces B: Biointerfaces 194, 111225, 2020 | 36 | 2020 |
| Nonordered dendritic mesoporous silica nanoparticles as promising platforms for advanced methods of diagnosis and therapies S Malekmohammadi, RUR Mohammed, H Samadian, A Zarebkohan, ... Materials Today Chemistry 26, 101144, 2022 | 35 | 2022 |
| An update on dual targeting strategy for cancer treatment YD Taghipour, A Zarebkohan, R Salehi, F Rahimi, VP Torchilin, ... Journal of Controlled Release 349, 67-96, 2022 | 34 | 2022 |
| Co-delivery of doxorubicin and conferone by novel pH-responsive β-cyclodextrin grafted micelles triggers apoptosis of metastatic human breast cancer cells A Rahmani, F Rahimi, M Iranshahi, H Kahroba, A Zarebkohan, M Talebi, ... Scientific Reports 11 (1), 21425, 2021 | 31 | 2021 |
Reza Rahbarghazi (Clinical Pathology...Head of Department of Applied Cell Sciences, TBZMEDZweryfikowany adres z tbzmed.ac.ir
